Geneos Wealth Management
SGEN

Geneos Wealth Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Geneos Wealth Management’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$144K – 2840
2022
Q1 		$144K Hold
1,000
– – 0.01% 948
2021
Q4 		$154K Hold
1,000
– – 0.01% 987
2021
Q3 		$173K Hold
1,000
– – 0.01% 924
2021
Q2 		$157K Hold
1,000
– – 0.01% 959
2021
Q1 		$143K Hold
1,000
– – ﹤0.01% 1135
2020
Q4 		$139K Buy
+1,000
New +$186K 0.01% 994

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geneos Wealth Management's SGEN Position: Q2 2022 in Review

Geneos Wealth Management sold out of Seagen Inc. Common Stock (SGEN) in Q2 2022, closing a stake of 1,000 shares — an estimated $144K sold.

Geneos Wealth Management first reported a position in SGEN in Q4 2020 and held it in 6 quarters. The position peaked at $173K in Q3 2021. 548 funds tracked by Wall St. Rank hold SGEN as of Q2 2022.

  • Geneos Wealth Management reported no remaining Seagen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 1,000 Seagen Inc. Common Stock shares in Q2 2022, an estimated $144K.
  • Geneos Wealth Management first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Geneos Wealth Management's Seagen Inc. Common Stock position peaked at $173K in Q3 2021.
  • 548 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.